TB-500
Peptiva
TB-500
ISKLJUČIVO ZA IN VITRO LABORATORIJSKA ISTRAŽIVANJA.
Nije namijenjen osobnoj, kliničkoj, dijagnostičkoj ili veterinarskoj primjeni niti primjeni na ljudima ili životinjama.
Description and specifications
What is TB-500?
TB-500 is the commercial name for research materials related to thymosin beta-4. The name is not always used for the same sequence: the exact identity, peptide length, and any modifications should be checked in the documentation for the specific batch.
Mechanism and Scientific Context
Full-length thymosin beta-4 is studied in the context of actin binding, cell migration, and tissue response to damage. These findings cannot be automatically attributed to a fragment or other material labeled as TB-500. Comparison requires matching the identity of the material studied and the material offered.
Main Research Areas
- cell migration and cytoskeleton remodeling
- angiogenesis and vascular response
- models of muscle and connective tissue regeneration
- inflammatory processes and scar formation
How to interpret research data?
Prioritize studies that specify the exact sequence and experimental model. Research on full-length thymosin beta-4 does not prove the efficacy of every commercial TB-500 batch, and preclinical findings do not confirm the safety or effectiveness of this product in humans.
Available Peptiva variants
- 5 mg · Lyophilized vial
- 5 mg · Research dispenser
- 10 mg · Lyophilized vial
- 10 mg · Research dispenser
Select an available variant and check its name, total content, and price. The photo is not a substitute for the declaration of the selected variant.
Packaging format and content
Research dispenser: The variant contains a complete filled dispenser with the selected content, not just a separate replacement cartridge. The quantity indicated with the variant refers to the total declared content, not the amount per individual use.
Lyophilized vial: The variant contains lyophilized material in a vial, without a dispenser. This description does not refer to bacteriostatic water or a separate empty container.
Storage and handling conditions depend on the specific formulation and batch declaration. The packaging format does not confirm sterility, dosing precision, stability, or suitability for use in humans or animals.
Important limitations
Evidence is predominantly preclinical. Research findings do not constitute confirmation of safety or efficacy for human use.
Batch Documentation
For inquiries about available COA documentation, please contact peptivacomhr@gmail.com with the product name and LOT number if known. Availability and scope of analyses are checked for the specific batch. COA itself does not prove sterility or suitability for use in humans or animals.
Purpose and limitations: This product is intended for laboratory research only. It is not intended for use in humans or animals, diagnosis, treatment, mitigation, or prevention of diseases. The description is not medical advice. The research-use-only label and packaging name do not, by themselves, determine the regulatory status of the product or prove its safety or sterility.
COA on request
To enquire about a certificate of analysis (COA), send the material name, requested variant and LOT / batch number if available. Documents are not published on this page.
Request a COA by emailThe button opens your email app with a prepared enquiry. You send the message yourself. peptivacomhr@gmail.com
A COA applies to a specific batch. A purity result alone does not establish sterility, absence of endotoxins or safety for use in humans or animals.